143 related articles for article (PubMed ID: 10536170)
1. Co-overexpression of p53 protein and epidermal growth factor receptor in human papillary thyroid carcinomas correlated with lymph node metastasis, tumor size and clinicopathologic stage.
Chen BK; Ohtsuki Y; Furihata M; Takeuchi T; Iwata J; Liang SB; Sonobe H
Int J Oncol; 1999 Nov; 15(5):893-8. PubMed ID: 10536170
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of c-Met protein in human thyroid tumors correlated with lymph node metastasis and clinicopathologic stage.
Chen BK; Ohtsuki Y; Furihata M; Takeuchi T; Iwata J; Liang SB; Sonobe H
Pathol Res Pract; 1999; 195(6):427-33. PubMed ID: 10399184
[TBL] [Abstract][Full Text] [Related]
3. High expression and localization of β-catenin and epidermal growth factor receptor identify high risk papillary thyroid carcinoma patients.
Išić Denčić T; Bartolome A; Šelemetjev S; Đorić I; Tatić S; Živaljević V; Cvejić D
Exp Mol Pathol; 2018 Oct; 105(2):181-189. PubMed ID: 30077672
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of epidermal growth factor receptor and its downstream effector, focal adhesion kinase, correlates with papillary thyroid carcinoma progression.
Šelemetjev S; Bartolome A; Išić Denčić T; Đorić I; Paunović I; Tatić S; Cvejić D
Int J Exp Pathol; 2018 Apr; 99(2):87-94. PubMed ID: 29665129
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of epidermal growth factor receptor, p53 and galectin-3 expression in papillary thyroid carcinoma.
Lee YM; Lee JB
J Int Med Res; 2013 Jun; 41(3):825-34. PubMed ID: 23569038
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of p53 protein expression in papillary thyroid carcinoma.
Morita N; Ikeda Y; Takami H
World J Surg; 2008 Dec; 32(12):2617-22. PubMed ID: 18836853
[TBL] [Abstract][Full Text] [Related]
7. High expression of GPER1, EGFR and CXCR1 is associated with lymph node metastasis in papillary thyroid carcinoma.
Tang C; Yang L; Wang N; Li L; Xu M; Chen GG; Liu ZM
Int J Clin Exp Pathol; 2014; 7(6):3213-23. PubMed ID: 25031742
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic and diagnostic significance of p53 protein expression in papillary thyroid carcinoma.
Shin MK; Kim JW
Asian Pac J Cancer Prev; 2014; 15(5):2341-4. PubMed ID: 24716981
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of vascular endothelial growth factor C in papillary thyroid carcinoma correlates with cervical lymph node metastases.
Yu XM; Lo CY; Chan WF; Lam KY; Leung P; Luk JM
Clin Cancer Res; 2005 Nov; 11(22):8063-9. PubMed ID: 16299237
[TBL] [Abstract][Full Text] [Related]
10. [Usefulness of the immunohistochemical analysis of several molecular markers in the characterization of papillary thyroid carcinoma with initial lymph node metastasis].
Zafón C; Castellví J; Obiols G
Endocrinol Nutr; 2010 Apr; 57(4):165-9. PubMed ID: 20403734
[TBL] [Abstract][Full Text] [Related]
11. Differential expression patterns and clinical significance of estrogen receptor-α and β in papillary thyroid carcinoma.
Huang Y; Dong W; Li J; Zhang H; Shan Z; Teng W
BMC Cancer; 2014 May; 14():383. PubMed ID: 24884830
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of p53 protein and MDM2 in papillary carcinomas of the thyroid: Correlations with clinicopathologic features.
Horie S; Maeta H; Endo K; Ueta T; Takashima K; Terada T
Pathol Int; 2001 Jan; 51(1):11-5. PubMed ID: 11148457
[TBL] [Abstract][Full Text] [Related]
13. [Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features].
Jiang XL; Zhang H; Chen YL; Peng L
Zhonghua Bing Li Xue Za Zhi; 2017 Mar; 46(3):160-165. PubMed ID: 28297755
[No Abstract] [Full Text] [Related]
14. Prognostic impact of p53, c-erbB-2 and epidermal growth factor receptor on head and neck carcinoma.
Parise Junior O; Carvalho LV; Miguel RE; Kowalski LP
Sao Paulo Med J; 2004 Nov; 122(6):264-8. PubMed ID: 15692721
[TBL] [Abstract][Full Text] [Related]
15. Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erbB-2, p53) expression and long-term prognosis.
Lipponen P; Eskelinen M
Br J Cancer; 1994 Jun; 69(6):1120-5. PubMed ID: 7911031
[TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor receptor expression correlates with poor prognosis in non-small cell lung cancer patients with p53 overexpression.
Ohsaki Y; Tanno S; Fujita Y; Toyoshima E; Fujiuchi S; Nishigaki Y; Ishida S; Nagase A; Miyokawa N; Hirata S; Kikuchi K
Oncol Rep; 2000; 7(3):603-7. PubMed ID: 10767376
[TBL] [Abstract][Full Text] [Related]
17. The expression of monocyte chemotactic protein-1 in papillary thyroid carcinoma is correlated with lymph node metastasis and tumor recurrence.
Tanaka K; Kurebayashi J; Sohda M; Nomura T; Prabhakar U; Yan L; Sonoo H
Thyroid; 2009 Jan; 19(1):21-5. PubMed ID: 19072670
[TBL] [Abstract][Full Text] [Related]
18. Thymosin beta 10 correlates with lymph node metastases of papillary thyroid carcinoma.
Zhang XJ; Su YR; Liu D; Xu DB; Zeng MS; Chen WK
J Surg Res; 2014 Dec; 192(2):487-93. PubMed ID: 24974154
[TBL] [Abstract][Full Text] [Related]
19. [The expression and significance of trefoil factor 3 and SDF-1/CXCR4 biological axis in papillary thyroid carcinoma].
Xue G; Huang J; Zhang H; Zhang W; Wu J; Shang X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Jan; 28(2):108-12. PubMed ID: 24738314
[TBL] [Abstract][Full Text] [Related]
20. The role of molecular markers and tumor histological type in central lymph node metastasis of papillary thyroid carcinoma.
Paulson L; Shindo M; Schuff K; Corless C
Arch Otolaryngol Head Neck Surg; 2012 Jan; 138(1):44-9. PubMed ID: 22249628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
